Forschung & Innovation
Publikationen
Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.
PMU Autor*innen
Verena Wally, Manuela Reisenberger, Sophie Kitzmüller, Martin Laimer
Alle Autor*innen
Verena Wally, Manuela Reisenberger, Sophie Kitzmüller, Martin Laimer
Fachzeitschrift
ORPHANET JOURNAL OF RARE DISEASES
Kurzfassung
Keywords
TRIAL, MANAGEMENT, DOUBLE-BLIND, EFFICACY, SIMPLEX, DIACEREIN, ORAL VISCOUS BUDESONIDE, PHENYTOIN THERAPY, BOTULINUM TOXIN, PRURIGINOSA